Skip to content
Search

Latest Stories

PSNC publish pharmacy representation progress update and a toolkit for LPCs

The Pharmaceutical Services Negotiating Committee (PSNC) has published an update on the work it is doing as part of the Transforming Pharmacy Representation (TAPR) Programme to take forward the mandate from contractors to deliver the Review Steering Group (RSG) recommendations.

The update is primarily aimed at LPCs – with whom PSNC has been working closely on some of the TAPR work over the summer.


The TAPR Programme is being undertaken in support of PSNC’s work to address the severe challenges facing the community pharmacy sector at present.

Alongside ongoing negotiations with Government and the NHS, two of the TAPR workstreams – focusing on Vision and Strategy, and on Influencing and Negotiation – are essential to supporting CPCF negotiations.

“The workstreams are looking at the future of community pharmacy and how best to persuade policymakers to implement a shared vision, with their objective being to put the sector in a stronger position going into future CPCF negotiations,” said PSNC.

“Other TAPR workstreams are being taken forward to enhance governance and to support the LPCs to make changes, with the ultimate aim that contractors should have a better relationship with, and more oversight of, stronger national and local negotiators in the future.”

As part of PSNC’s support for LPCs to make the changes set out by the RSG, earlier this week it held two online sessions with LPCs.

The committee has also published Phase 1 of an LPC Toolkit. “Contractors can expect to hear from LPCs about discussions on possible changes at LPC level in the autumn.”

The update provides an overview of all of this work, giving a description of each of the TAPR Programme workstreams and milestones.

PSNC chief executive Janet Morrison said: “Community pharmacy contractors are facing immense challenges at the moment and everyone at PSNC is working tirelessly and with a sharp focus on getting them the help they so urgently need. But as well as making the case for short-term support on things like energy bills, we must also have an eye to the long-term sustainability of the sector: it has always been my view that the bigger prize for the sector is what comes after the current five-year CPCF.

Through the TAPR Programme work we are beginning to prepare for that longer-term future, working hard to put PSNC, the LPCs and ultimately the community pharmacy sector in a stronger position for future negotiations.”

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less